SC
REGN icon

Solstein Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Solstein Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Hold
69
– – 0.01% 240
2026
Q1 		$53.3K Sell
69
-2
-3% -$1.53K 0.02% 221
2025
Q4 		$54.8K Sell
71
-137
-66% -$93K 0.02% 203
2025
Q3 		$117K Sell
208
-40
-16% -$22.6K 0.03% 148
2025
Q2 		$130K Sell
248
-41
-14% -$22.9K 0.07% 134
2025
Q1 		$183K Sell
289
-10
-3% -$6.88K 0.11% 101
2024
Q4 		$213K Hold
299
– – 0.12% 91
2024
Q3 		$314K Hold
299
– – 0.17% 83
2024
Q2 		$314K Sell
299
-72
-19% -$69.8K 0.21% 78
2024
Q1 		$357K Hold
371
– – 0.25% 71
2023
Q4 		$326K Hold
371
– – 0.24% 72
2023
Q3 		$305K Sell
371
-12
-3% -$9.43K 0.26% 71
2023
Q2 		$275K Buy
383
+30
+8% +$23.1K 0.23% 72
2023
Q1 		$290K Buy
353
+89
+34% +$67.1K 0.25% 72
2022
Q4 		$190K Sell
264
-16
-6% -$11.8K 0.16% 93
2022
Q3 		$193K Buy
280
+5
+2% +$3.15K 0.17% 82
2022
Q2 		$163K Sell
275
-5
-2% -$3.25K 0.12% 112
2022
Q1 		$196K Sell
280
-738
-72% -$467K 0.13% 114
2021
Q4 		$643K Buy
1,018
+969
+1,978% +$596K 0.39% 71
2021
Q3 		$30K Hold
49
– – 0.02% 278
2021
Q2 		$27K Buy
49
+2
+4% +$1.01K 0.03% 269
2021
Q1 		$22K Buy
+47
New +$22.9K 0.03% 248
2020
Q4 		– Sell
-47
Closed -$26K – 182
2020
Q3 		$26K Hold
47
– – 0.06% 163
2020
Q2 		$29K Hold
47
– – 0.07% 146
2020
Q1 		$23K Hold
47
– – 0.09% 133
2019
Q4 		$18K Buy
+47
New +$15.8K 0.04% 204

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Solstein Capital's REGN Position: Q2 2026 in Review

Solstein Capital held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 69 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #240.

Solstein Capital first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $643K in Q4 2021. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Solstein Capital held 69 shares of Regeneron Pharmaceuticals worth $43K as of Q2 2026.
  • Solstein Capital left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Solstein Capital's portfolio in Q2 2026, its #240 holding.
  • Solstein Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • Solstein Capital's Regeneron Pharmaceuticals position peaked at $643K in Q4 2021.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.